[1] Balasubramani M, Day BW, Schoen RE, et al. Altered expression and localization of creatine kinase B, heterogeneous nuclear ribonucleoprotein F, and high mobility group box 1 protein in the nuclear matrix associated with colon cancer [J]. Cancer Res, 2006, 66(2): 763-769.
[2] Yu C, Guo J, Liu Y, et al. Oral squamous cancer cell exploits hnRNP A1 to regulate cell cycle and proliferation [J]. J Cell Physiol, 2015, 230(9): 2252-2261.
[3] Jia R, Zhang S, Liu M, et al. HnRNP L is important for the expression of oncogene SRSF3 and oncogenic potential of oral squamous cell carcinoma cells [J]. Sci Rep, 2016, 6: 35976.
[4] Radhakrishnan A, Nanjappa V, Raja R, et al. Dysregulation of splicing proteins in head and neck squamous cell carcinoma [J]. Cancer Biol Ther, 2016, 17(2): 219-229.
[5] 刘佩琦,石黎明,贾荣. SRSF3调控口腔癌细胞中SPAG5外显子3的可变剪切的研究[J]. 口腔医学研究, 2016, 32(1): 8-11.
[6] 张偲,刘苗苗,刘佩琦,等. HnRNP L调控口腔癌细胞中CD55内含子7的可变剪切的研究[J]. 口腔医学研究, 2016, 32(10): 1006-1009.
[7] Tyson-Capper A, Gautrey H. Regulation of Mcl-1 alternative splicing by hnRNP F, H1 and K in breast cancer cells [J]. RNA Biol, 2018, 15(12): 1448-1457.
[8] Ghosh A, Zhao S, Lo CS, et al. Heterogeneous nuclear ribonucleoprotein F mediates insulin inhibition of bcl2-modifying factor expression and tubulopathy in diabetic kidney [J]. Sci Rep, 2019, 9(1): 6687.
[9] Nibbe RK, Markowitz S, Myeroff L, et al. Discovery and scoring of protein interaction subnetworks discriminative of late stage human colon cancer [J]. Mol Cell Proteomics, 2009, 8(4): 827-845.
[10] Li F, Zhao H, Su M, et al. HnRNP-F regulates EMT in bladder cancer by mediating the stabilization of Snail1 mRNA by binding to its 3' UTR [J]. EBioMedicine, 2019, 45: 208-219.
[11] Goh ET, Pardo OE, Michael N, et al. Involvement of heterogeneous ribonucleoprotein F in the regulation of cell proliferation via the mammalian target of rapamycin/S6 kinase 2 pathway [J]. J Biol Chem, 2010, 285(22): 17065-17076. |
